Despite the toll #ChronicKidneyDisease #Anemia takes on energy levels, daily activities, and overall health, treatment options remain limited, leaving many patients without effective solutions. At Disc Medicine, we’re working to change that. We aim to develop innovative new therapies addressing the underlying mechanism of #CKD anemia that could improve outcomes and quality of life for those affected. This #WorldKidneyDay, we recognize the critical need for better treatment options and remain dedicated to pioneering research that drives meaningful progress for people living with CKD anemia. Learn more about our unique approach and pipeline at https://lnkd.in/g3gE-Dk6
Disc Medicine
生物技术研究
Watertown，Massachusetts 4,573 位关注者
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders.
关于我们
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.
- 网站
-
https://www.discmedicine.com
Disc Medicine的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，Massachusetts
- 类型
- 上市公司
地点
-
主要
获取路线
321 Arsenal St.
Suite 101
US，Massachusetts，Watertown，02472-5710
Disc Medicine员工
动态
-
Honoring the strength of the #Porphyria community this #RareDiseaseDay —your voices make a difference!
Happy Rare Disease Day to our Porphyria friends from around the world! On this special day, we focus on the many rare diseases and take the opportunity to generate some awareness. Why not talk to just one person about porphyria or share your colours and talk about the impact porphyria has had on you or a loved one! The global porphyria community is strong in advocating collectively to ensure you are not alone with our porphyria! Staggeringly, each one of us is just 1 in the 300 million living around the world with a rare disease!
-
-
We’re proud to stand with the #Porphyria community this #RareDiseaseDay! We're inspired by the incredible efforts of advocates and fundraisers helping to support patients and families.
It’s #RareDiseaseDay! We wanted to take the opportunity of today’s spotlight on #RareDisease to say thank you to all of our amazing community members who have gone above and beyond in the past year to make a difference through their incredible fundraising efforts. From fun runs and half marathons to Dungeons and Dragons livestreams and golf club tournaments, every step, every mile, and every roll of the dice has helped us continue our mission of supporting families living with #Porphyria. We couldn’t be more grateful for all your hard work and dedication. Read all about our incredible fundraisers in our latest newsletter at https://ow.ly/cxJR50V8fwe ?? #Fundraising #CareforRare #PorphyriaTogether #RareDisease #RareDiseaseDay #PorphyriaNews #ShareYourColours #MyPorphyria Global Porphyria Advocacy Coalition
-
-
The theme for Rare Disease Day 2025 "More Than You Can Imagine" reminds us to think beyond the limits of current treatment and embrace the boundless potential of research, innovation, and hope for those living with a #RareDisease. While these conditions may seem insurmountable, the breakthroughs ahead are far greater than we can imagine. At Disc Medicine, we are pushing the boundaries of #Hematology research and advancing therapies that have the potential to transform the lives of those with rare #Hematologic conditions. The future of rare disease care is full of possibilities and we’re proud to be part of it. Learn more about #RareDiseaseDay at https://lnkd.in/dE56sfWf and discover more about Disc at https://lnkd.in/g-dvi3C9 #EPP #XLP #Myelofibrosis #Anemia #PolycythemiaVera
-
We are proud to partner with Shadow Jumpers, supporting this year’s Spin-a-Thon, to help make an impact for photosensitive families! At Disc, we’re dedicated to developing treatments that alleviate suffering and empower patients to live vibrant lives. Thanks to this incredible fundraiser, more families will get the help they need. #EPP #XLP
After this past Saturday's Los Angeles Charity Ride, we are happy to report that our total raised for this year's Spin Away the Sun Fundraiser, $116,421, has officially surpassed the grand total of all four of our previous Spin-a-Thon fundraisers COMBINED ($114k). We cannot thank our hundred of donors, 50 riders across two locations and our 20 incredible sponsors enough. From sun proof vacations, home renovations, travel assistance, our Sun Escape Camp and more, we will make you proud the rest of 2025 putting your generosity towards more photosensitive families then ever before. Thank you!
-
-
On #WorldAnemiaAwarenessDay, we are reminded of the critical need for new treatments that target key molecular drivers of #Anemia. At Disc Medicine, we are advancing investigational therapies that have the potential to transform care for patients with serious #Hematologic conditions. Recent data from Phase 1b clinical trials of DISC-0974 showed promising results in myelofibrosis-related anemia and non-dialysis-dependent chronic kidney disease anemia, highlighting the potential of our pipeline to meet significant unmet needs. Learn more about our latest research and commitment to innovation: https://lnkd.in/g3gE-Dk6 #Myelofibrosis #ChronicKidneyDisease
-
Today Disc Medicine announced positive feedback from its Type C meeting with the FDA to discuss the APOLLO post-marketing confirmatory trial for #Bitopertin in #EPP. Join us for our corporate call today at 8am ET. Please register for the event on the Events and Presentations page of Disc’s website. Read more: https://lnkd.in/eRQVBNKD
-
2024 was a year of meaningful accomplishments for our #Hematology portfolio, from discussions with the FDA on the registrational pathway for #Bitopertin in #EPP and #XLP to the generation of positive data for DISC-0974 and DISC-3405. As we build on this momentum, we’re excited to advance our clinical programs in 2025, striving toward meaningful progress for patients with #Hematological diseases. Learn more: https://lnkd.in/ePbZARMM #Myelofibrosis #KidneyDisease #PolycythemiaVera
-
Medscape members: Disc teamed up with Medscape to bring you an exclusive Med Ed webinar featuring our #ASH24 presentations on both BEACON and AURORA Phase 2 clinical trial results for #Bitopertin. Don’t miss this opportunity to explore key insights and advancements in #EPP and #XLP. Watch BEACON here: https://lnkd.in/eGQHFURZ Watch AURORA here: https://lnkd.in/ec7Tun5a
-
Thank you,?BiotechTV, for spotlighting our #ASH24 positive clinical and translational data?updates with CEO?John Quisel! Learn more about the latest progress on bitopertin, DISC-0974, and DISC-3405 in the full video:?https://lnkd.in/giB68Fz6
?????? ????????: Disc Medicine's CEO John Quisel shares an update on three programs, including an oral presentation for an anti-anemia antibody for patients with myelofibrosis and potentially beyond in the future. He shares an update on #ASH24 data for DISC-0974, bitopertin, and DISC-3405. Full video: https://lnkd.in/giB68Fz6 BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | NYSE | Allucent | Klein Hersh